Ifirmacombi European Union - English - EMA (European Medicines Agency)

ifirmacombi

krka, d.d., novo mesto - irbesartan, hydrochlorothiazide - hypertension - agents acting on the renin-angiotensin system - treatment of essential hypertension. this fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.

DERMACOMBIN OINTMENT Israel - English - Ministry of Health

dermacombin ointment

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - ointment - triamcinolone acetonide 1 mg/g; neomycin as sulfate 2.5 mg/g; gramicidin 0.25 mg/g; nystatin 100000 iu/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

DERMACOMBIN CREAM Israel - English - Ministry of Health

dermacombin cream

taro pharmaceutical industries ltd - gramicidin; neomycin as sulfate; nystatin; triamcinolone acetonide - cream - nystatin 100000 iu/g; gramicidin 0.25 mg/g; neomycin as sulfate 2.5 mg/g; triamcinolone acetonide 1 mg/g - triamcinolone and antibiotics - triamcinolone and antibiotics - for the relief of corticosteroid-responsive inflammatory or pruritic dermatoses caused, threatened or complicated by infection due to bacteria and/or candida

ESTRACOMBI TTS Ireland - English - HPRA (Health Products Regulatory Authority)

estracombi tts

novartis pharmaceuticals uk ltd - estradiol hemihydrate norethisterone acetate estradiol hemihydrate - transdermal patch - 50/50/250 microgram/day

ESTRACOMBI TTS 50/50/250 Microgram/day Transdermal Patch Ireland - English - HPRA (Health Products Regulatory Authority)

estracombi tts 50/50/250 microgram/day transdermal patch

novartis pharmaceuticals uk ltd - estradiol hemihydrate norethisterone acetate estradiol hemihydrate - transdermal patch - 50/50/250 microgram/day

Estracombi TTS New Zealand - English - Medsafe (Medicines Safety Authority)

estracombi tts

novartis new zealand ltd - estradiol 4mg (releases 50 µg/24 hours);  ; estradiol 10mg (releases 50 µg/24 hours); norethisterone acetate 30mg (releases 0.25 mg/24 hours);   - transdermal patch - active: estradiol 4mg (releases 50 µg/24 hours)   excipient: ethanol hyprolose active: estradiol 10mg (releases 50 µg/24 hours) norethisterone acetate 30mg (releases 0.25 mg/24 hours)   excipient: ethanol hyprolose